Cargando…

New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases

Squamous cell carcinomas of the lung, head and neck, esophagus, and cervix account for more than two million cases of cancer per year worldwide with very few targetable therapies available and minimal clinical improvement in the past three decades. Although these carcinomas are differentiated anatom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bensen, Ryan, Brognard, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999493/ https://www.ncbi.nlm.nih.gov/pubmed/33799513 http://dx.doi.org/10.3390/ijms22062831

Ejemplares similares

Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets
por: Torres-Ayuso, Pedro, et al.
Publicado: (2019)

Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer
por: Torres-Ayuso, Pedro, et al.
Publicado: (2022)

Orange is the new black: Kinases are the new master regulators of tumor suppression
por: An, Elvira, et al.
Publicado: (2018)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
por: Makowska, Karolina, et al.
Publicado: (2023)

Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities
por: Su, Shih-Chi, et al.
Publicado: (2017)

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas
por: Kirtane, Kedar, et al.
Publicado: (2022)

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
por: Lindsay, Cameron, et al.
Publicado: (2017)

Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
por: De Angelis, Maria Laura, et al.
Publicado: (2019)

The landscape of driver mutations in cutaneous squamous cell carcinoma
por: Chang, Darwin, et al.
Publicado: (2021)

The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma
por: Wang, Yujia, et al.
Publicado: (2020)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
por: Panchal, Omkar, et al.
Publicado: (2020)

Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins
por: Schäfer, Mirijam, et al.
Publicado: (2021)

New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway
por: Alfieri, Roberta, et al.
Publicado: (2017)

Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities
por: Guscetti, Franco, et al.
Publicado: (2020)

The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma
por: Tian, Ying, et al.
Publicado: (2020)

Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
por: Yanagi, Teruki, et al.
Publicado: (2018)

Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors
por: Boscolo-Rizzo, Paolo, et al.
Publicado: (2017)

Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas
por: Lin, De-Chen, et al.
Publicado: (2018)

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities
por: Mahmoud, Ahmed M, et al.
Publicado: (2023)

Motives for Crafting Work and Leisure: Focus on Opportunities at Work and Psychological Needs as Drivers of Crafting Efforts
por: Kosenkranius, Merly, et al.
Publicado: (2021)

Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier
por: Vargas-Rodríguez, Pablo, et al.
Publicado: (2023)

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
por: Chin, Venessa T., et al.
Publicado: (2015)

An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma
por: Sawada, Genta, et al.
Publicado: (2015)

Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
por: Atanasio, Amanda, et al.
Publicado: (2022)

Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022)

Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action
por: Wu, Hucong, et al.
Publicado: (2019)

Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule
por: Christen, Urs, et al.
Publicado: (2020)

Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment
por: Vodstrcil, Lenka A., et al.
Publicado: (2021)

Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets
por: Yang, Eddy S., et al.
Publicado: (2017)

Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect
por: Zhang, Yuxi, et al.
Publicado: (2020)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

PReS-FINAL-2173: Protein kinase C delta deficiency is a new cause of monogenic SLE
por: Belot, A, et al.
Publicado: (2013)

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
por: Fania, Luca, et al.
Publicado: (2021)

New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
por: Hirsh, Vera
Publicado: (2017)

Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
por: Vasudev, Naveen S., et al.
Publicado: (2011)

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
por: Boni, Jacopo, et al.
Publicado: (2020)

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart
por: Nassal, Drew, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t0fqfsujno36bsf1bd46eo0v9n